RFESDP1

Across TCGA pan-cancer cohorts, RFESDP1 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RFESDP1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RFESDP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RFESDP1 expression acts as an unfavorable survival marker, although some lineages such as UCS and THYM show a favorable association.

LUAD, UCS, and MESO are the cancer types where RFESDP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.677	0.813	<.001	132	view →
UCS	OS	Tertile	II,III,IV	0.706	0.214	.002	60	view →
MESO	DFS	Tertile	IV	0.107	0.409	.001	49	view →
UVM	OS	Tertile	All	0.248	0.769	.007	18	view →
BRCA	DFS	Tertile	II,III,IV	0.913	0.948	.026	6	view →
THYM	DFS	Median	II,III,IV	0.896	0.551	.034	4	view →
LIHC	OS	Tertile	III,IV	0.858	0.601	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RFESDP1–LUAD (DFS)

Open the LUAD breakdown →